Novel Therapeutics in Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories:
Immune dysregulation
Abnormal skin barrier
Abnormal itch/scratch cycle
Abnormal skin microbiome
In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi …
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories:
Immune dysregulation
Abnormal skin barrier
Abnormal itch/scratch cycle
Abnormal skin microbiome
In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi … 
Every time I think of Marta Rendon, I smile…before, now and forever more.
Simply put, Marta brought joy. To her family; her handsome son, Juan, her long-time life partner, Dr. Bret Ribotsky and her siblings. To her patients. To her business partners and employees of her practice. To any and every dermatologist throughout the US and abroad that she supported and mentored. To those of us in der … 
On this Mnemonic Monday, we challenge you to remember drugs commonly causing AGEP, or acute generalized exanthematous pustulosis. These drugs include:
Beta-lactam antibiotics
Calcium channel blockers
Cephalosporins
Macrolide antibiotics
Mercury
Mnemonic:
ABC MICKEY MOUSE
AGEP
Beta- Lactam
Calcium channel blockers, cephalosporins
Macrolides
Mercury
Click HERE to down … 
Closing defects under tension in areas such as the scalp and back may be challenging during dermatologic surgery. Different techniques have been advocated to ease the placement of the first deep suture under tension, including the slip-knot stitch, pully stitch, horizontal mattress suture, pulley set-back dermal suture, and tandem pulley stitch.
INTRODUCTION
Closing defects under tension in … 
Dr. Hanke, a dermatologic surgeon who needs no introduction (but I’ll give one anyway!) provided us with an evidence-based discussion of field treatments available for actinic keratoses at ODAC 2021 conference.
Just to name a few of Dr. Hanke’s accomplishments, he is the current Senior Vice President of the Skin Cancer Foundation, Senior editor of JDD, and the former president of the AAD, A …